ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 570

$726K Total Retail Price of All Prescriptions

Rank: 39 out of 570

335 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
FLUTICASONE PROPIONATE 673 579 1 19
SIMVASTATIN 591 544 2 6
AMLODIPINE BESYLATE 497 458 3 7
OMEPRAZOLE 486 409 4 5
WARFARIN SODIUM 417 346 5 16
FUROSEMIDE 412 393 6 10
LOSARTAN POTASSIUM 354 323 7 23
LISINOPRIL 351 331 8 11
LEVOTHYROXINE SODIUM 342 302 9 8
PREDNISONE 314 289 10 3
POTASSIUM CHLORIDE 287 261 11 24
METFORMIN HCL 278 237 12 14
HYDROCODONE-ACETAMINOPHEN 221 171 S3 13 9
ALLOPURINOL 220 173 14 55
LACTULOSE 212 197 15 90
PANTOPRAZOLE SODIUM 210 166 16 21
METOPROLOL TARTRATE 186 143 17 18
ATENOLOL 182 170 18 22
CARVEDILOL 173 151 19 33
DONEPEZIL HCL 160 160 20 35
POLYETHYLENE GLYCOL 3350 149 115 21 111
TRAMADOL HCL 148 139 22 31
ATORVASTATIN CALCIUM 136 128 23 20
GABAPENTIN 131 89 24 25
FAMOTIDINE 131 113 24 41
METOPROLOL SUCCINATE 130 105 26 44
SPIRONOLACTONE 130 124 26 77
JANUVIA 119 114 28 58
TAMSULOSIN HCL 119 106 28 37
LOVASTATIN 119 114 28 34
NAMENDA 116 116 31 50
DIGOXIN 113 103 32 46
SINGULAIR 111 105 33 15
LANTUS 110 101 34 52
ZOLPIDEM TARTRATE 105 91 35 17
ALBUTEROL SULFATE 104 99 36 30
BENAZEPRIL HCL 94 94 37 42
CLOPIDOGREL 91 82 38 48
SERTRALINE HCL 89 82 39 61
HUMALOG 83 82 40 125
MIRTAZAPINE 82 82 41 65
HYDRALAZINE HCL 79 68 42 113
SPIRIVA 78 71 43 1
IPRATROPIUM BROMIDE 78 75 43 39
NOVOLOG 77 65 45 104
METOCLOPRAMIDE HCL 76 60 46 81
PLAVIX 74 69 47 68
ADVAIR DISKUS 73 64 48 2
DOXAZOSIN MESYLATE 72 67 49 110
QUETIAPINE FUMARATE 72 60 49 97
FENOFIBRATE 71 61 51 109
MONTELUKAST SODIUM 68 62 52 29
PROAIR HFA 68 61 52 4
HYDROCHLOROTHIAZIDE 68 68 52 26
TRIAMCINOLONE ACETONIDE 66 49 55 62
BUSPIRONE HCL 64 64 56 174
CLONIDINE HCL 63 33 57 49
ATROVENT HFA 63 50 57 159
ALENDRONATE SODIUM 62 43 59 28
GEMFIBROZIL 62 46 59 118
CYMBALTA 61 51 61 93
PRAVASTATIN SODIUM 54 48 62 43
LABETALOL HCL 52 52 63 218
LEVETIRACETAM 51 35 64 67
CITALOPRAM HBR 51 46 64 82
FLUOXETINE HCL 50 45 66 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.